Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry

Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of stroke and cerebrovascular diseases 2010-05, Vol.19 (3), p.190-197
Hauptverfasser: Uchiyama, Shinichiro, MD, PhD, Shibata, Yoshisato, MD, PhD, Hirabayashi, Takayuki, MD, PhD, Mihara, Ban, MD, PhD, Hamashige, Naohisa, MD, PhD, Kitagawa, Kazuo, MD, PhD, Goto, Shinya, MD, PhD, Origasa, Hideki, PhD, Shimada, Kazuyuki, MD, PhD, Kobayashi, Hiroyuki, MD, PhD, Isozaki, Mitsuhiro, PhD, Ikeda, Yasuo, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 197
container_issue 3
container_start_page 190
container_title Journal of stroke and cerebrovascular diseases
container_volume 19
creator Uchiyama, Shinichiro, MD, PhD
Shibata, Yoshisato, MD, PhD
Hirabayashi, Takayuki, MD, PhD
Mihara, Ban, MD, PhD
Hamashige, Naohisa, MD, PhD
Kitagawa, Kazuo, MD, PhD
Goto, Shinya, MD, PhD
Origasa, Hideki, PhD
Shimada, Kazuyuki, MD, PhD
Kobayashi, Hiroyuki, MD, PhD
Isozaki, Mitsuhiro, PhD
Ikeda, Yasuo, MD, PhD
description Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index > 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events.
doi_str_mv 10.1016/j.jstrokecerebrovasdis.2009.04.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733894563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1052305709000822</els_id><sourcerecordid>733894563</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</originalsourceid><addsrcrecordid>eNqVUk2P0zAQjRCIXRb-AvINCW3C2I6bhANSqSgs6gq0C2fLHxPkNI2LnVSq9s-vQxcOiAunscZP782bN1n2mkJBgS7edEUXx-C3aDCgDv6gonWxYABNAWUBUD7KzqngLK8FpY_TGwTLOYjqLHsWYwdAqajF0-yMQclLKMV5dnfj4paslRl9IF-Db12PkfiW3P5SuiTXR29UsE715GpoVTCj88MlUYMlyzHM7bXTwfW9mj_ekiX5rPZqwIjkeupHZ3AYMZCV93sMCXNAcoM_XDJyfJ49aVUf8cVDvci-rz98W33KN18-Xq2Wm9wIVo45bYxl2iJwTlWlKqx1xRe6plrohS1tg1WLyVEFjWlrppmmteZNYy1waqHlF9mrE-8--J8TxlHuXDSYRh7QT1FWnNdNKRY8Id-fkCb4GAO2ch_cToWjpCDnDGQn_5WBnDOQUMqUQSJ5-SA36R3aPxS_l54AmxMAk-mDwyCjcTgYtC6gGaX17v_03v1FZ3o3OKP6LR4xdn4KQ1qvpDIyCfJ2vor5KKABgJoxfg-4zL0s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733894563</pqid></control><display><type>article</type><title>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Uchiyama, Shinichiro, MD, PhD ; Shibata, Yoshisato, MD, PhD ; Hirabayashi, Takayuki, MD, PhD ; Mihara, Ban, MD, PhD ; Hamashige, Naohisa, MD, PhD ; Kitagawa, Kazuo, MD, PhD ; Goto, Shinya, MD, PhD ; Origasa, Hideki, PhD ; Shimada, Kazuyuki, MD, PhD ; Kobayashi, Hiroyuki, MD, PhD ; Isozaki, Mitsuhiro, PhD ; Ikeda, Yasuo, MD, PhD</creator><creatorcontrib>Uchiyama, Shinichiro, MD, PhD ; Shibata, Yoshisato, MD, PhD ; Hirabayashi, Takayuki, MD, PhD ; Mihara, Ban, MD, PhD ; Hamashige, Naohisa, MD, PhD ; Kitagawa, Kazuo, MD, PhD ; Goto, Shinya, MD, PhD ; Origasa, Hideki, PhD ; Shimada, Kazuyuki, MD, PhD ; Kobayashi, Hiroyuki, MD, PhD ; Isozaki, Mitsuhiro, PhD ; Ikeda, Yasuo, MD, PhD ; J-TRACE Investigators</creatorcontrib><description>Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index &gt; 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events.</description><identifier>ISSN: 1052-3057</identifier><identifier>EISSN: 1532-8511</identifier><identifier>DOI: 10.1016/j.jstrokecerebrovasdis.2009.04.004</identifier><identifier>PMID: 20434045</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; atrial fibrillation ; Atrial Fibrillation - epidemiology ; Cardiomyopathy, Dilated - complications ; Cardiomyopathy, Dilated - epidemiology ; Cardiovascular ; Cohort Studies ; Data Interpretation, Statistical ; Diabetes Mellitus - epidemiology ; Female ; Fibrinolytic Agents - therapeutic use ; Humans ; Hypercholesterolemia - complications ; Hypercholesterolemia - epidemiology ; Hypertension - complications ; Hypertension - drug therapy ; Hypertension - epidemiology ; Japan - epidemiology ; Male ; Middle Aged ; myocardial infarction ; Myocardial Infarction - drug therapy ; Myocardial Infarction - epidemiology ; Neurology ; Registries ; Registry ; Risk factor ; Risk Factors ; stroke ; Stroke - drug therapy ; Stroke - epidemiology ; Thrombosis - complications</subject><ispartof>Journal of stroke and cerebrovascular diseases, 2010-05, Vol.19 (3), p.190-197</ispartof><rights>National Stroke Association</rights><rights>2010 National Stroke Association</rights><rights>Copyright (c) 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</citedby><cites>FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2009.04.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20434045$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uchiyama, Shinichiro, MD, PhD</creatorcontrib><creatorcontrib>Shibata, Yoshisato, MD, PhD</creatorcontrib><creatorcontrib>Hirabayashi, Takayuki, MD, PhD</creatorcontrib><creatorcontrib>Mihara, Ban, MD, PhD</creatorcontrib><creatorcontrib>Hamashige, Naohisa, MD, PhD</creatorcontrib><creatorcontrib>Kitagawa, Kazuo, MD, PhD</creatorcontrib><creatorcontrib>Goto, Shinya, MD, PhD</creatorcontrib><creatorcontrib>Origasa, Hideki, PhD</creatorcontrib><creatorcontrib>Shimada, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Kobayashi, Hiroyuki, MD, PhD</creatorcontrib><creatorcontrib>Isozaki, Mitsuhiro, PhD</creatorcontrib><creatorcontrib>Ikeda, Yasuo, MD, PhD</creatorcontrib><creatorcontrib>J-TRACE Investigators</creatorcontrib><title>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</title><title>Journal of stroke and cerebrovascular diseases</title><addtitle>J Stroke Cerebrovasc Dis</addtitle><description>Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index &gt; 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events.</description><subject>Aged</subject><subject>atrial fibrillation</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Cardiomyopathy, Dilated - complications</subject><subject>Cardiomyopathy, Dilated - epidemiology</subject><subject>Cardiovascular</subject><subject>Cohort Studies</subject><subject>Data Interpretation, Statistical</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Humans</subject><subject>Hypercholesterolemia - complications</subject><subject>Hypercholesterolemia - epidemiology</subject><subject>Hypertension - complications</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Japan - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>myocardial infarction</subject><subject>Myocardial Infarction - drug therapy</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Neurology</subject><subject>Registries</subject><subject>Registry</subject><subject>Risk factor</subject><subject>Risk Factors</subject><subject>stroke</subject><subject>Stroke - drug therapy</subject><subject>Stroke - epidemiology</subject><subject>Thrombosis - complications</subject><issn>1052-3057</issn><issn>1532-8511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVUk2P0zAQjRCIXRb-AvINCW3C2I6bhANSqSgs6gq0C2fLHxPkNI2LnVSq9s-vQxcOiAunscZP782bN1n2mkJBgS7edEUXx-C3aDCgDv6gonWxYABNAWUBUD7KzqngLK8FpY_TGwTLOYjqLHsWYwdAqajF0-yMQclLKMV5dnfj4paslRl9IF-Db12PkfiW3P5SuiTXR29UsE715GpoVTCj88MlUYMlyzHM7bXTwfW9mj_ekiX5rPZqwIjkeupHZ3AYMZCV93sMCXNAcoM_XDJyfJ49aVUf8cVDvci-rz98W33KN18-Xq2Wm9wIVo45bYxl2iJwTlWlKqx1xRe6plrohS1tg1WLyVEFjWlrppmmteZNYy1waqHlF9mrE-8--J8TxlHuXDSYRh7QT1FWnNdNKRY8Id-fkCb4GAO2ch_cToWjpCDnDGQn_5WBnDOQUMqUQSJ5-SA36R3aPxS_l54AmxMAk-mDwyCjcTgYtC6gGaX17v_03v1FZ3o3OKP6LR4xdn4KQ1qvpDIyCfJ2vor5KKABgJoxfg-4zL0s</recordid><startdate>20100501</startdate><enddate>20100501</enddate><creator>Uchiyama, Shinichiro, MD, PhD</creator><creator>Shibata, Yoshisato, MD, PhD</creator><creator>Hirabayashi, Takayuki, MD, PhD</creator><creator>Mihara, Ban, MD, PhD</creator><creator>Hamashige, Naohisa, MD, PhD</creator><creator>Kitagawa, Kazuo, MD, PhD</creator><creator>Goto, Shinya, MD, PhD</creator><creator>Origasa, Hideki, PhD</creator><creator>Shimada, Kazuyuki, MD, PhD</creator><creator>Kobayashi, Hiroyuki, MD, PhD</creator><creator>Isozaki, Mitsuhiro, PhD</creator><creator>Ikeda, Yasuo, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100501</creationdate><title>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</title><author>Uchiyama, Shinichiro, MD, PhD ; Shibata, Yoshisato, MD, PhD ; Hirabayashi, Takayuki, MD, PhD ; Mihara, Ban, MD, PhD ; Hamashige, Naohisa, MD, PhD ; Kitagawa, Kazuo, MD, PhD ; Goto, Shinya, MD, PhD ; Origasa, Hideki, PhD ; Shimada, Kazuyuki, MD, PhD ; Kobayashi, Hiroyuki, MD, PhD ; Isozaki, Mitsuhiro, PhD ; Ikeda, Yasuo, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-19cd2bde0331a7a7e8b736b81b5b6d4d9e7fe204709cf82b2b18b399dd031d0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Aged</topic><topic>atrial fibrillation</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Cardiomyopathy, Dilated - complications</topic><topic>Cardiomyopathy, Dilated - epidemiology</topic><topic>Cardiovascular</topic><topic>Cohort Studies</topic><topic>Data Interpretation, Statistical</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Humans</topic><topic>Hypercholesterolemia - complications</topic><topic>Hypercholesterolemia - epidemiology</topic><topic>Hypertension - complications</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Japan - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>myocardial infarction</topic><topic>Myocardial Infarction - drug therapy</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Neurology</topic><topic>Registries</topic><topic>Registry</topic><topic>Risk factor</topic><topic>Risk Factors</topic><topic>stroke</topic><topic>Stroke - drug therapy</topic><topic>Stroke - epidemiology</topic><topic>Thrombosis - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uchiyama, Shinichiro, MD, PhD</creatorcontrib><creatorcontrib>Shibata, Yoshisato, MD, PhD</creatorcontrib><creatorcontrib>Hirabayashi, Takayuki, MD, PhD</creatorcontrib><creatorcontrib>Mihara, Ban, MD, PhD</creatorcontrib><creatorcontrib>Hamashige, Naohisa, MD, PhD</creatorcontrib><creatorcontrib>Kitagawa, Kazuo, MD, PhD</creatorcontrib><creatorcontrib>Goto, Shinya, MD, PhD</creatorcontrib><creatorcontrib>Origasa, Hideki, PhD</creatorcontrib><creatorcontrib>Shimada, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Kobayashi, Hiroyuki, MD, PhD</creatorcontrib><creatorcontrib>Isozaki, Mitsuhiro, PhD</creatorcontrib><creatorcontrib>Ikeda, Yasuo, MD, PhD</creatorcontrib><creatorcontrib>J-TRACE Investigators</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of stroke and cerebrovascular diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uchiyama, Shinichiro, MD, PhD</au><au>Shibata, Yoshisato, MD, PhD</au><au>Hirabayashi, Takayuki, MD, PhD</au><au>Mihara, Ban, MD, PhD</au><au>Hamashige, Naohisa, MD, PhD</au><au>Kitagawa, Kazuo, MD, PhD</au><au>Goto, Shinya, MD, PhD</au><au>Origasa, Hideki, PhD</au><au>Shimada, Kazuyuki, MD, PhD</au><au>Kobayashi, Hiroyuki, MD, PhD</au><au>Isozaki, Mitsuhiro, PhD</au><au>Ikeda, Yasuo, MD, PhD</au><aucorp>J-TRACE Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry</atitle><jtitle>Journal of stroke and cerebrovascular diseases</jtitle><addtitle>J Stroke Cerebrovasc Dis</addtitle><date>2010-05-01</date><risdate>2010</risdate><volume>19</volume><issue>3</issue><spage>190</spage><epage>197</epage><pages>190-197</pages><issn>1052-3057</issn><eissn>1532-8511</eissn><abstract>Objective We sought to clarify risk factor profiles and current treatment of Japanese patients with stroke, myocardial infarction (MI), and nonvalvular atrial fibrillation (NVAF) using the database of the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE). Methods J-TRACE is a nationwide multicenter cooperative cohort of Japanese patients with MI, stroke, and NVAF. Baseline characteristics of 8087 Japanese patients (5804 male, average age 68.7 years) with history of stroke (n = 3554), MI (n = 2291), or NVAF (n = 2242) were analyzed. Results History of stroke (14.7%) was more frequent than history of MI (2.6%) in patients with stroke, whereas history of stroke (6.6%) was less frequent than history of MI (7.6%) in patients with MI. In patients with NVAF, history of stroke (14.3%) was far more frequent than history of MI (3.4%). Hypertension was more frequent in stroke (74.4%) than MI (62.0%) or NVAF (57.7%), whereas hypercholesterolemia, diabetes mellitus, and cigarette smoking were more prevalent in patients with MI (56.1%, 35.1%, and 33.3%, respectively) than in those with stroke (35.7%, 22.4%, and 19.7%, respectively) or NVAF (26.9%, 17.2%, and 16.1%, respectively). Alcohol consumption (34.9%) and obesity (body mass index &gt; 25) (32.8%) were most common in patients with NVAF. In all patients, nonmedication rates were higher in patients with hypercholesterolemia (29.8%) or diabetes (36.9%) than in those with hypertension (9.5%). Warfarin was used in 58.9% of patients with low-risk and 75.4% with high-risk NVAF. Conclusion Risk factor profiles and their modification were not similar among patients in Japan with MI, stroke, and NVAF, although they share a high risk of thrombotic events.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20434045</pmid><doi>10.1016/j.jstrokecerebrovasdis.2009.04.004</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1052-3057
ispartof Journal of stroke and cerebrovascular diseases, 2010-05, Vol.19 (3), p.190-197
issn 1052-3057
1532-8511
language eng
recordid cdi_proquest_miscellaneous_733894563
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Aged
atrial fibrillation
Atrial Fibrillation - epidemiology
Cardiomyopathy, Dilated - complications
Cardiomyopathy, Dilated - epidemiology
Cardiovascular
Cohort Studies
Data Interpretation, Statistical
Diabetes Mellitus - epidemiology
Female
Fibrinolytic Agents - therapeutic use
Humans
Hypercholesterolemia - complications
Hypercholesterolemia - epidemiology
Hypertension - complications
Hypertension - drug therapy
Hypertension - epidemiology
Japan - epidemiology
Male
Middle Aged
myocardial infarction
Myocardial Infarction - drug therapy
Myocardial Infarction - epidemiology
Neurology
Registries
Registry
Risk factor
Risk Factors
stroke
Stroke - drug therapy
Stroke - epidemiology
Thrombosis - complications
title Risk Factor Profiles of Stroke, Myocardial Infarction, and Atrial Fibrillation: A Japanese Multicenter Cooperative Registry
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T08%3A23%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20Factor%20Profiles%20of%20Stroke,%20Myocardial%20Infarction,%20and%20Atrial%20Fibrillation:%20A%20Japanese%20Multicenter%20Cooperative%20Registry&rft.jtitle=Journal%20of%20stroke%20and%20cerebrovascular%20diseases&rft.au=Uchiyama,%20Shinichiro,%20MD,%20PhD&rft.aucorp=J-TRACE%20Investigators&rft.date=2010-05-01&rft.volume=19&rft.issue=3&rft.spage=190&rft.epage=197&rft.pages=190-197&rft.issn=1052-3057&rft.eissn=1532-8511&rft_id=info:doi/10.1016/j.jstrokecerebrovasdis.2009.04.004&rft_dat=%3Cproquest_cross%3E733894563%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733894563&rft_id=info:pmid/20434045&rft_els_id=S1052305709000822&rfr_iscdi=true